IPP Bureau
Morepen Laboratories net profit up 189%
By IPP Bureau - May 05, 2021
R&D Centre will be housed in Baddi and will cater to all business divisions in addition to expansion plans for all its verticals including APls, Formulations and Medical Devices
Natco receives emergency use approval for Baricitinib tablets
By IPP Bureau - May 05, 2021
The company will be requesting a Compulsory License based on emergency use and in light of the grave and serious public health emergency across India due to the Pandemic
Govt. gives order for 16 cr COVID-19 vaccine doses
By IPP Bureau - May 04, 2021
As of 2nd May 2021, the Government has provided more 16.54 crore COVID-19 vaccine doses to States/UTs free of cost
Glenmark launches Ryaltris-AZ at affordable price
By IPP Bureau - May 04, 2021
First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg
RPG Life Sciences reports Rs. 6.92 crore PAT in Q4 FY2020-21
By IPP Bureau - May 03, 2021
The company reported total income of Rs.390.05 crores during the 12 months period ended March 31, 2021
Ajanta Pharma Q4FY21 consolidated PAT drops QoQ to Rs. 159.26 Cr
By IPP Bureau - May 03, 2021
The companyreported total income of Rs.2915.67 crores during the 12 months period ended March 31, 2021
Gujarat Themis Biosyn Q4FY21 net profit lower at Rs. 5.79 Cr
By IPP Bureau - May 03, 2021
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
India to import 450,000 vials of Remdesivir
By IPP Bureau - May 01, 2021
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
Reliance produces 1000 MTPD medical grade liquid oxygen
By IPP Bureau - May 01, 2021
This oxygen is being provided free-of-cost to several state governments across the country to bring immediate relief to over 1 lakh patients on a daily basis
Dr. Reddy's launches Albendazole tablets in US
By IPP Bureau - April 30, 2021
Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two
Lonza and Moderna enter new agreement to double drug substance production for COVID-19 vaccine
By IPP Bureau - April 30, 2021
New agreement for three further production lines at Lonza’s site in Visp, Switzerland
Cipla signs agreement with Merck for Molnupiravir
By IPP Bureau - April 29, 2021
Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19
Glenmark’s Ryaltris nasal spray approved in Europe
By IPP Bureau - April 27, 2021
In some countries such as France, Italy, Spain and the Balkan region, Menarini Group will lead the commercialisation effort, as part of an exclusive licensing agreement signed with Glenmark
Vaishali Pharma bags order worth US $270,000 from Afghanistan
By IPP Bureau - April 26, 2021
This achievement enables the company to strengthen its presence in the high growth market of South Asian countries
Govt. approves 25 manufacturing sites for Remdesivir production
By IPP Bureau - April 26, 2021
The production capacity is now ramped up to 90 lakh vials per month whereas earlier it was 40 lakh vials/month
